Volumetric stratification of cT4 stage head and neck cancer
Authors:
Open Access
- 5 September 2013
- journal article
- research article
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 189 (10) , 867-873
Abstract
Background: Locoregionally advanced stage head and neck cancer (HNC) is known for unfavorable outcome with only ~ 40–50 % 3-year overall survival (OS). Clinical T4 stage includes a wide range of tumor burden. The lack of further nonsurgical subgrouping of cT4 stage makes intercenter outcome of irradiated cohorts difficult. Aim of this analysis was to further stratify cT4 stage HNC using volumetric staging. Material and methods: Between January 2002 and January 2013, a total of 201 cT4 stage squamous cell cancer (SCC) HNC patients referred to our center for curative definitive radiation were consecutively irradiated. Radiation was performed using modulated techniques. Total gross tumor volumes (tGTV: primary + nodal tumor volume) of all patients have retrospectively been stratified using a prospectively evaluated volumetric staging system which bases on 3 cut-offs (15/70/130 ml), translating into 4 prognostic subgroups [V1: 1–15 ml (n = 15), V2: 16–70 ml (108), V3: 71–130 ml (62), V4: > 130 ml (16)]. OS, disease-free survival (DFS), locoregional control (LRC), and distant metastasis-free survival (DMFS) rates were calculated. Results: The mean/median follow-up was 31/23 months (range 1–116 months). The 3-year OS, DFS, LRC, and DMFS rates of the entire cohort were 63, 44, 48, and 77 %, respectively. Volumetric staging revealed its potential to prognostically statistically significantly divide the cT4 cohort into 4 volume subgroups (V1/2/3/4): OS: 90 %/72 %/58 %/18 %; DFS: 83 %/50 %/39 %/10 %; LRC: 81 %/53 %/47 %/15 %; DMFS: 93 %/90 %/70 %/41 %, all p < 0.0001. Conclusion: Volumetric staging allowed a highly statistically significant stratification of cT4 HNC stages into prognostic subgroups, which offers the chance of better intercenter comparability of irradiated advanced stage HNC cohorts.Keywords
This publication has 38 references indexed in Scilit:
- Volumetric staging in oropharyngeal cancer patients treated with definitive IMRTOral Oncology, 2013
- Impact of tumor volume and systemic therapy on outcome in patients undergoing IMRT for large volume head neck cancerRadiation Oncology, 2011
- Long-term outcome and patterns of failure in patients with advanced head and neck cancerRadiation Oncology, 2011
- Clinical Efficacy of Primary Tumor Volume Measurements: Comparison of Different Primary SitesClinical and Experimental Otorhinolaryngology, 2009
- Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinomaHead & Neck, 2008
- Long-Term Results of Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-14)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Primary tumor volume calculation as a predictive factor of prognosis in nasopharyngeal carcinomaActa Oto-Laryngologica, 2008
- Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRTActa Oncologica, 2007
- Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Irradiation alone for supraglottic larynx carcinoma: Can CT findings predict treatment results?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1990